Risk assessment of nanomaterials presents unique challenges, including:
Limited data on the long-term effects of nanomaterials Difficulty in measuring and characterizing nanomaterials in complex matrices Lack of standardized testing methods and protocols Uncertainty in extrapolating data from animal models to humans
